Ekso Bionics Holdings, Inc. Common Stock Q2 FY2025 Earnings Call

Operator: Greetings, and welcome to the Ekso Bionics Second Quarter 2025 Financial Results Conference Call. [Operator Instructions]. It is now my pleasure to introduce your host, Stephen Kilmer, Investor Relations. Thank you. You may begin. Stephen Kilmer: Thank you, operator, and good afternoon, everyone. Earlier today, Ekso Bionics released financial results for the second quarter ended June 30, 2025. A copy of the press release is available on our website. I would like to point out that management will make statements during this call that include forward-looking statements within the meaning of the federal securities laws, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements made during this call that are not statements of historical facts should be deemed to be forward- looking statements. All forward-looking statements, including statements regarding our business strategy, future financial or operational expectations, our ability to close on delayed customer sales, our expectations of the regulatory landscape governing our products and operations are based upon management's current estimates and various assumptions. These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated or implied by these forward- looking statements. Accordingly, you should not place undue reliance on these statements. For a list and descripti